Package 82442-967-02

{"route": ["OPHTHALMIC"], "spl_id": "32c0905b-361c-1ee3-e063-6394a90a2bdd", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["355df5ce-95e2-4d05-9114-a3190d934d3a"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (82442-967-02)  / 3.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "82442-967-02", "marketing_start_date": "20250415"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "82442-967_32c0905b-361c-1ee3-e063-6394a90a2bdd", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "82442-967", "generic_name": "Olopatadine Hydrochloride Ophthalmic Solution", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA206087", "marketing_category": "ANDA", "marketing_start_date": "20250415", "listing_expiration_date": "20261231"}